vedolizumab,axicabtagene ciloleucel,gemcitabine,brentuximab vedotin,tisagenlecleucel
gilead,takeda,seagen,daiichi sankyo,novartis 
['t-cell lymphoma', 'gemcitabine', 'brentuximab', 'lysa', 'lymphoma', ' vedo', 'peripheral t-cell lymphoma']
[lysa oral ash 22] presentation by olivier tournilhac at on the total trial, a lysa study find other lysa presentations here: stay tuned, more is coming ! #ash22 #lymphoma #study #congress 
A cooperative group committed to lymphoma research   Visit our website: https://t.co/qhgmlKQkxz